|
1
|
Bernt KM and Hunger SP: Current concepts
in pediatric Philadelphia chromosome-positive acute lymphoblastic
leukemia. Front Oncol. 4:542014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Quintás-Cardama A and Cortes J: Molecular
biology of bcr-abl1-positive chronic myeloid leukemia. Blood.
113:1619–1630. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Schjerven H, Ayongaba EF, Aghajanirefah A,
McLaughlin J, Cheng D, Geng H, Boyd JR, Eggesbø LM, Lindeman I,
Heath JL, et al: Genetic analysis of Ikaros target genes and tumor
suppressor function in BCR-ABL1+ pre-B ALL. J Exp Med.
214:793–814. 2017.PubMed/NCBI
|
|
4
|
Pfeifer H, Wassmann B, Hofmann WK, Komor
M, Scheuring U, Brück P, Binckebanck A, Schleyer E, Gökbuget N,
Wolff T, et al: Risk and prognosis of central nervous system
leukemia in patients with Philadelphia chromosome-positive acute
leukemias treated with imatinib mesylate. Clin Cancer Res.
9:4674–4681. 2003.PubMed/NCBI
|
|
5
|
Mullighan CG: The molecular genetic makeup
of acute lymphoblastic leukemia. Hematology Am Soc Hematol Educ
Program. 2012:389–396. 2012.PubMed/NCBI
|
|
6
|
Hamdi A, Mawad R, Bassett R, di SA, Ferro
R, Afrough A, Ram R, Dabaja B, Rondon G, Champlin R, et al: Central
nervous system relapse in adults with acute lymphoblastic leukemia
after allogeneic hematopoietic stem cell transplantation. Biol
Blood Marrow Transplant. 20:1767–1771. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Trendowski M: The inherent metastasis of
leukaemia and its exploitation by sonodynamic therapy. Crit Rev
Oncol Hematol. 94:149–163. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jabbour E, Thomas D, Cortes J, Kantarjian
HM and O'Brien S: Central nervous system prophylaxis in adults with
acute lymphoblastic leukemia: Current and emerging therapies.
Cancer. 116:2290–2300. 2010.PubMed/NCBI
|
|
9
|
Arbonés ML, Ord DC, Ley K, Ratech H,
Maynard-Curry C, Otten G, Capon DJ and Tedder TF: Lymphocyte homing
and leukocyte rolling and migration are impaired in
L-selectin-deficient mice. Immunity. 1:247–260. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Campbell JJ, Hedrick J, Zlotnik A, Siani
MA, Thompson DA and Butcher EC: Chemokines and the arrest of
lymphocytes rolling under flow conditions. Science. 279:381–384.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ley K, Laudanna C, Cybulsky MI and
Nourshargh S: Getting to the site of inflammation: The leukocyte
adhesion cascade updated. Nat Rev Immunol. 7:678–689. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nourshargh S, Hordijk PL and Sixt M:
Breaching multiple barriers: Leukocyte motility through venular
walls and the interstitium. Nat Rev Mol Cell Biol. 11:366–378.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yao H, Price TT, Cantelli G, Ngo B, Warner
MJ, Olivere L, Ridge SM, Jablonski EM, Therrien J, Tannheimer S, et
al: Leukaemia hijacks a neural mechanism to invade the central
nervous system. Nature. 560:55–60. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Peng C and Li S: CML mouse model in
translational research. Methods Mol Biol. 602:253–266. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Roumiantsev S, de Aos IE, Varticovski L,
Ilaria RL and Van Etten RA: The src homology 2 domain of Bcr/Abl is
required for efficient induction of chronic myeloid leukemia-like
disease in mice but not for lymphoid leukemogenesis or activation
of phosphatidylinositol 3-kinase. Blood. 97:4–13. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li S, Ilaria RL, Million RP Jr, Daley GQ
and Van Etten RA: The P190, P210, and P230 forms of the BCR/ABL
oncogene induce a similar chronic myeloid leukemia-like syndrome in
mice but have different lymphoid leukemogenic activity. J Exp Med.
189:1399–1412. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Maheras KJ and Gow A: Increased anesthesia
time using 2,2,2-tribromoethanol-chloral hydrate with low impact on
mouse psychoacoustics. J Neurosci Method. 219:61–69. 2013.
View Article : Google Scholar
|
|
18
|
Anderson KG, Mayer-Barber K, Sung H, Beura
L, James BR, Taylor JJ, Qunaj L, Griffith TS, Vezys V, Barber DL
and Masopust D: Intravascular staining for discrimination of
vascular and tissue leukocytes. Nat Protoc. 9:209–222. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Krause DS, Katherine L, Lewis JB, Andrian
UH and Van Etten RA: Selectins and their ligands are required for
homing and engraftment of BCR-ABL1+ leukemic stem cells
in the bone marrow niche. Blood. 123:1361–1371. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Levinsen M, Taskinen M, Abrahamsson J,
Forestier E, Frandsen TL, Harila-Saari A, Heyman M, Jonsson OG,
Lähteenmäki PM, Lausen B, et al: Clinical features and early
treatment response of central nervous system involvement in
childhood acute lymphoblastic leukemia. Pediatr Blood Cancer.
61:1416–1421. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Camicia R, Winkler HC and Hassa PO: Novel
drug targets for personalized precision medicine in
relapsed/refractory diffuse large B-cell lymphoma: A comprehensive
review. Mol Cancer. 14:2072015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Krause S, Pfeiffer C, Strube S, Alsadeq A,
Fedders H, Vokuhl C, Loges S, Waizenegger J, Ben-Batalla I, Cario
G, et al: Mer tyrosine kinase promotes the survival of
t(1;19)-positive acute lymphoblastic leukemia (ALL) in the central
nervous system (CNS). Blood. 125:820–830. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Buchner M, Swaminathan S, Chen Z and
Müschen M: Mechanisms of pre-B-cell receptor checkpoint control and
its oncogenic subversion in acute lymphoblastic leukemia. Immunol
Rev. 263:192–209. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Score J, Calasanz MJ, Ottman O, Pane F,
Yeh RF, Sobrinho-Simões MA, Kreil S, Ward D, Hidalgo-Curtis C, Melo
JV, et al: Analysis of genomic breakpoints in p190 and p210 BCR-ABL
indicate distinct mechanisms of formation. Leukemia. 24:1742–1750.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gu S, Sayad A, Chan G, Yang W, Lu Z,
Virtanen C, Van Etten RA and Neel BG: SHP2 is required for
BCR-ABL1-induced hematologic neoplasia. Leukemia. 32:203–213. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Dong Y, Liu F, Wu C, Li S, Zhao X, Zhang
P, Jiao J, Yu X, Ji Y and Zhang M: Illegitimate RAG-mediated
recombination events are involved in IKZF1 Δ3–6 deletion in
BCR-ABL1 lymphoblastic leukaemia. Clin Exp Immunol. 185:320–331.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Morotti A, Panuzzo C, Crivellaro S,
Pergolizzi B, Familiari U, Berger AH, Saglio G and Pandolfi PP:
BCR-ABL disrupts PTEN nuclear-cytoplasmic shuttling through
phosphorylation-dependent activation of HAUSP. Leukemia.
28:1326–1333. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Dash AB, Williams IR, Kutok JL, Tomasson
MH, Anastasiadou E, Lindahl K, Li S, Van Etten RA, Borrow J,
Housman D, et al: A murine model of CML blast crisis induced by
cooperation between BCR/ABL and NUP98/HOXA9. Proc Natl Acad Sci
USA. 99:7622–7627. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang H, Peng C, Hu Y, Li H, Sheng Z, Chen
Y, Sullivan C, Cerny J, Hutchinson L, Higgins A, et al: The Blk
pathway functions as a tumor suppressor in chronic myeloid leukemia
stem cells. Nat Genet. 44:861–871. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Vegh P, Winckler J and Melchers F:
Long-term ‘in vitro’ proliferating mouse hematopoietic progenitor
cell lines. Immunol Lett. 130:32–35. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Holl TM, Haynes BF and Kelsoe G: Stromal
cell independent B cell development in vitro: Generation and
recovery of autoreactive clones. J Immunol Methods. 354:53–67.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ji Y, Resch W, Corbett E, Yamane A,
Casellas R and Schatz DG: The in vivo pattern of binding of RAG1
and RAG2 to antigen receptor loci. Cell. 141:419–431. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Dong Y, Wu C, Zhao X, Zhang P, Zhang H,
Zheng M, Li S, Jiao J, Yu X, Lv Z and Ji Y: Epigenetic
modifications of the VH region after DJH recombination in Pro-B
cells. Immunology. 152:218–231. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hardy RR and Hayakawa K: B cell
development pathways. Annu Rev Immunol. 19:595–621. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wu C, Dong Y, Zhao X, Zhang P, Zheng M,
Zhang H, Li S, Jin Y, Ma Y, Ren H and Ji Y: RAG2 involves the Igκ
locus demethylation during B cell development. Mol Immunol.
88:125–134. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Pippard MJ, Callender ST and Sheldon PW:
Infiltration of central nervous system in adult acute myeloid
leukaemia. Br Med J. 1:227–229. 1979. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Prieto C, López-Millán B, Roca-Ho H, Stam
RW, Romero-Moya D, Rodríguez-Baena FJ, Sanjuan-Pla A, Ayllón V,
Ramírez M, Bardini M, et al: NG2 antigen is involved in leukemia
invasiveness and central nervous system infiltration in
MLL-rearranged infant B-ALL. Leukemia. 32:633–644. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Roddie P, Collie D and Johnson P:
Myelomatous involvement of the dura mater: A rare complication of
multiple myeloma. J Clin Pathol. 53:398–399. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Cheung LC, Tickner J, Hughes AM, Skut P,
Howlett M, Foley B, Oommen J, Wells JE, He B, Singh S, et al: New
therapeutic opportunities from dissecting the pre-B leukemia bone
marrow microenvironment. Leukemia. 32:2326–2338. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Colognato H, ffrench-Constant C and Feltri
ML: Human diseases reveal novel roles for neural laminins. Trends
Neurosci. 28:480–486. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wang L, Dong Z, Zhang Y and Miao J: The
roles of integrin β4 in vascular endothelial cells. J Cell Physiol.
227:474–478. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Salomão DR, Pulido JS, Johnston PB,
Canal-Fontcuberta I and Feldman AL: Vitreoretinal presentation of
secondary large B-cell lymphoma in patients with systemic lymphoma.
JAMA Ophthalmol. 131:1151–1158. 2013. View Article : Google Scholar : PubMed/NCBI
|
